In parallel, the Pharmacogenomics Research Network (PRGN) will hold a two-day preconference on pharmacogenetics on October 15-16, 2018. See the meeting website here. The conference runs 1:00-7:30 on Monday and 8:00-4:00 on Tuesday.
I've clipped the conference summary below. See the PRGN conference website for full agenda.
The Pharmacogenomics Research Network (PGRN) is bringing together scientists who study the interactions between genomes and drug response. This symposium, organized by the PGRN and open to all ASHG attendees and others, explores current topics in pharmacogenomics with sessions on the role of genetics in drug development, pharmacogenetic implementation, multiple genome considerations and precision drug therapy. In addition, a joint session with ASHG on Day 2 will focus on drug development for rare genetic diseases and immunopharmacogenomics.
We hope this symposium will help bridge the pharmacogenomics and genetics communities and enable scientists to identify new opportunities for advancing research in basic and translational pharmacogenomics.
The agenda includes the following sessions (scroll down to view full agenda):
- Session 1: The Role of Human Genetics in Drug Development from Target Identification to Clinical Trials
- Session 2: Challenges and Opportunities in Pharmacogenetic Implementation
- Session 3: Dual Genomes in Pharmacogenomics
- Session 4: Panel Discussion on Genomics and Precision Drug Therapy
- Session 5: Pharmacogenomics: Rare Diseases and Rare Adverse Drug Reactions
- Part 1: Drug Development for Rare Genetic Diseases
- Part 2: Immunopharmacogenomics